Effects of intermittent fasting on cardiovascular biomarkers, lipid metabolism, and general cardiovascular health

Abstract

Relevance: dyslipidemia and metabolic disorders are key contributors to cardiovascular diseases (CVDs), which continue to be the world's leading cause of morbidity and mortality. Due to the inconsistent results of traditional dietary therapies, there is growing interest in intermittent fasting (IF) as a substitute. Improved lipid metabolism, increased insulin sensitivity, and decreased inflammation—all important components of cardiovascular health—have been associated with intermittent fasting (IF), which alternates between periods of fasting and eating. Even with encouraging first findings, long-term cardiovascular effects are still unknown and need more investigation.